Oppenheimer Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Oppenheimer Asset Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,807	Closed	-$794K	–	1250
2021 Q2	$794K	Sell	4,807 -68	-1%	-$11.4K	0.01%	816
2021 Q1	$748K	Buy	+4,875	New	+$662K	0.01%	810
2020 Q2	–	Sell	-1,622	Closed	-$135K	–	1508
2020 Q1	$135K	Buy	1,622 +243	+18%	+$23.7K	﹤0.01%	1048
2019 Q4	$153K	Buy	+1,379	New	+$142K	﹤0.01%	1114

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Oppenheimer Asset Management's PRAH Position: Q3 2021 in Review

Oppenheimer Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 4,807 shares — an estimated $794K sold.

Oppenheimer Asset Management first reported a position in PRAH in Q4 2019 and held it in 4 quarters. The position peaked at $794K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Oppenheimer Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Oppenheimer Asset Management sold 4,807 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $794K.
Oppenheimer Asset Management first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 4 quarters.
Oppenheimer Asset Management's PRA Health Sciences, Inc. position peaked at $794K in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Oppenheimer Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.